Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study 7: Effect of an armband over a physostigmine + hyoscine transdermal patch
ISRCTN13607674Phase 2Completed
- Sponsor
- Defence Science and Technology Laboratory
- Start
- Mar 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 2, randomised, open-label trial of physostigmine and scopolamine in nerve agent poisoning (6 arms), sponsored by Defence Science and Technology Laboratory. Primary endpoints: Physostigmine plasma concentration, Hyoscine plasma concentration and 1 more. Started Mar 2008; status: completed.
02
Drugs
physostigminescopolamine
03
Conditions
nerve agent poisoning
Beyond the preview
Go deeper on ISRCTN13607674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13607674.